iRhythm Technologies, Inc.

Equities

IRTC

US4500561067

Advanced Medical Equipment & Technology

Market Closed - Nasdaq Other stock markets 16:00:00 2024-05-17 EDT			5-day change	1st Jan Change
94.83 ^USD	-3.92%		-4.22%	-11.41%

05-03	Needham Adjusts iRhythm Technologies' PT to $138 From $137, Says 'Strong' Q1 Revenue Growth Should Continue; Keeps Buy Rating	MT
05-02	Transcript : IRhythm Technologies, Inc., Q1 2024 Earnings Call, May 02, 2024

IRhythm Technologies, Inc. Revises Earnings Guidance for the Year 2024

May 02, 2024 at 04:05 pm

iRhythm Technologies, Inc. revised earnings guidance for the year 2024. The company projects revenue for the full year 2024 to grow approximately 17% to 19% compared to prior year results, ranging from approximately $578 million to $588 million.

Latest news about iRhythm Technologies, Inc.

Needham Adjusts iRhythm Technologies' PT to $138 From $137, Says 'Strong' Q1 Revenue Growth Should Continue; Keeps Buy Rating	05-03	MT
Transcript : IRhythm Technologies, Inc., Q1 2024 Earnings Call, May 02, 2024	05-02
Earnings Flash (IRTC) IRHYTHM Posts Q1 Revenue $131.9M, vs. Street Est of $128.4M	05-02	MT
IRhythm Technologies, Inc. Revises Earnings Guidance for the Year 2024	05-02	CI
IRhythm Technologies, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	05-02	CI
IRhythm Technologies Closes $661 Million Notes Offering	03-08	MT
Irhythm Technologies Insider Sold Shares Worth $360,983, According to a Recent SEC Filing	03-05	MT
IRhythm Technologies Prices $575 Million Convertible Notes Offering	03-05	MT
IRhythm Shares Fall After Firm Plans $450 Million Convertible Notes Offering	03-04	MT
IRhythm Technologies Plans to Offer $450 in Convertible Notes Due 2029	03-04	MT
Needham Adjusts iRhythm Technologies' Price Target to $137 From $136, Keeps Buy Rating	02-23	MT
IRhythm Technologies Q4 Adjusted Loss Widens, Revenue Rises; 2024 Sales Outlook Set -- Shares Slump After Hours	02-22	MT
Transcript : IRhythm Technologies, Inc., Q4 2023 Earnings Call, Feb 22, 2024	02-22
IRhythm Technologies, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023	02-22	CI
IRhythm Technologies, Inc. Provides Earnings Guidance for the Year 2024	02-22	CI
IRhythm Technologies, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	02-22	CI
Transcript : IRhythm Technologies, Inc. Presents at J.P. Morgan 42nd Annual Healthcare Conference 2024, Jan-08-2024 04:30 PM	01-08
IRhythm Technologies Closes $150 Million Debt Facility; 2024 Revenue Forecast Issued	01-08	MT
Needham Raises iRhythm Technologies' Price Target to $136 From $108, Keeps Buy Rating	01-08	MT
Irhythm Technologies, Inc. Entered into A Credit, Security and Guaranty Agreement with Braidwell Transaction Holdings LLC	01-08	CI
IRhythm Technologies, Inc. Revises Revenue Guidance for the Year 2024	01-08	CI
IRhythm Technologies Says Study Shows Zio Has 'Higher Diagnostic Yield' Compared With Other Cardiac Monitors	01-05	MT
IRhythm , Inc. Announces Results from the Cardiac Ambulatory Monitor EvaLuation of Outcomes and Time to Events	01-05	CI
Irhythm Technologies Insider Sold Shares Worth $745,692, According to a Recent SEC Filing	01-04	MT
IRhythm Technologies Says it Obtained EU CE Mark for Zio Monitor, Zeus System	01-03	MT

Chart iRhythm Technologies, Inc.

Duration

Period

More charts

Company Profile

iRhythm Technologies, Inc. is a digital health care company, which creates solutions that detect, predict, and prevent disease. The Company designs, develops, and commercializes device-based technology to provide ambulatory cardiac monitoring services. It offers three Zio System options: the Zio Monitor System, the Zio XT System, and the Zio AT System. It offers its Zio ambulatory cardiac monitoring services, including long-term continuous monitoring, short-term continuous monitoring, and mobile cardiac telemetry monitoring services (Zio Services), using its Zio Systems. The Zio Monitor System is a prescription-only, remote ECG monitoring system that consists of a patch ECG monitor (the Zio Monitor patch) that records the electric signal from the heart continuously for up to 14 days and the Zio ECG Utilization Software (ZEUS) System, which supports the capture and analysis of ECG data recorded by the Zio Monitor patch at the end of the wear period.

Sector

Advanced Medical Equipment & Technology

Calendar

2024-05-29 - Annual General Meeting

Related indices

Russell 2000

More about the company